Dr. Stelios B. Papadopoulos, Ph.D., is an Independent Director of BG Medicine, Inc. He has served as Chairman of Fondation Sant, a private charitable foundation whose mission is to provide support for research and education in the life sciences. Dr. Papadopoulos served as Vice Chairman of Cowen and Company, LLC from 2003 until 2006 and as Managing Director from 2000 until 2003. While at Cowen and Company, LLC, he worked as an investment banker focused on the biotech and pharmaceutical sectors. Prior to joining Cowen and Company, LLC, he worked as an investment banker at PaineWebber, Incorporated, from 1987 to 2000, where he was Chairman of PaineWebber Development Corporationration, a PaineWebber subsidiary focusing on biotechnology from 1996 to 2000. Dr. Papadopoulos is a cofounder and Chairman of the Board of Exelixis, Inc. Dr. Papadopoulos currently serves as chairman of the board of Regulus Therapeutics, Inc. and Biogen Inc. and he is a member of the board of directors of Joule Unlimited, Inc. During the past five years, he also served on the board of directors of Anadys Pharmaceuticals, Inc., and Cellzome, Inc. . He is also a member of the board of visitors of Duke University School of Medicine and the board of Global Advisors of the Duke Institute of Health Innovation
Age: 67 Director Since 2012 MBAPapadopoulos holds a Ph.D. in biophysics and an M.B.A. in finance, both from New York University.